1. Home
  2. LTC vs TYRA Comparison

LTC vs TYRA Comparison

Compare LTC & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LTC Properties Inc.

LTC

LTC Properties Inc.

HOLD

Current Price

$39.50

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$26.32

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTC
TYRA
Founded
1992
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
LTC
TYRA
Price
$39.50
$26.32
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
$40.00
$47.50
AVG Volume (30 Days)
568.1K
612.0K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
5.96%
N/A
EPS Growth
23.53
N/A
EPS
1.05
N/A
Revenue
$262,854,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.60
N/A
Revenue Growth
25.26
N/A
52 Week Low
$33.64
$9.96
52 Week High
$43.00
$40.65

Technical Indicators

Market Signals
Indicator
LTC
TYRA
Relative Strength Index (RSI) 46.75 34.98
Support Level $37.82 $24.77
Resistance Level $39.65 $32.82
Average True Range (ATR) 0.91 1.76
MACD -0.34 -0.66
Stochastic Oscillator 32.34 10.04

Price Performance

Historical Comparison
LTC
TYRA

About LTC LTC Properties Inc.

LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: